Skip to main content

Table 2 Seroprevalence rates and GMTs of EV71 and CoxA16 neutralizing antibodies among age groups

From: Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China

Neutralizing antibody 0–6-month-old 7–11-month-old 1–3-year-old 4–5-year-old
EV71 Seroprevalence rates (95%CI)
27.8 7.5 47.5 83.8
(23.2-37.8) (3.5-13.8) (38.3-56.8) (73.9-91.1)
GMTs (95%CI)
6.8 4.5 30.2 105.8
(6.1-7.6) (4.1-5.1) (19.8-46.0) (68.2-164.2)
CoxA16 Seroprevalence rates (95%CI)
8.9 17.5 50.8 66.3
(6.2-12.3) (11.2-25.5) (41.6-60.0) (54.8-76.4)
GMTs (95%CI)
4.6 5.9 12.6 16.6
(4.4-4.8) (5.0-7.0) (9.9-15.9) (12.4-22.1)